Home
/
ZENAS BIOPHARMA, INC. (ZBIO)
ZENAS BIOPHARMA, INC. (ZBIO) Technical Analysis
Updated: 2026-03-17 00:41 UTC · Last close: 23.23 (-3.37%)
ZENAS BIOPHARMA, INC. (ZBIO) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
ZENAS BIOPHARMA, INC. (ZBIO) closed at 23.23 (-3.37%). The chart remains in a constructive trend regime, with price holding above both the 50-day and 200-day moving averages. 20-day momentum is notably weak at -12.01%, with price remains inside its roughly 52-week range (6.77–43.17), while ATR14 volatility is elevated at roughly 7.61% of price. RSI(14) is 40.8, leaving momentum in a fairly neutral range. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. The nearest decision zone is framed by support at 23.23 and resistance at 25.39. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Revenue: 10.00M · Net income: -137.29M · EPS (basic): -3.27. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
Fundamentals Snapshot
Source: sec
Company
ZENAS BIOPHARMA, INC.
Note: This is an algorithmic technical snapshot (not financial advice).